{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:28:13Z","timestamp":1790278093765,"version":"4.1.0"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:p>\n                    Dry eye disease (DED) is a multifactorial and common ophthalmic disease that has a tremendous effect on the quality of life. It is now becoming a public health concern because of our changing lifestyle and environment. The current treatment modalities, artificial tear substitutes, and anti-inflammatory therapy are directed at dry eye symptoms. One of the major drivers for DED is oxidative stress, and the polyphenol group of natural compounds has the potential to reduce the same. Resveratrol, widely found in the skin of grapes and nuts, has antioxidative and anti-inflammatory properties. It has been shown to have beneficial effects in glaucoma, age-related macular degeneration, retinopathy of prematurity, uveitis, and diabetic retinopathy. Studies have also explored the beneficial effects of resveratrol in DED, making it as a promising therapeutic molecule. Resveratrol has not yet reached clinical application because of difficulty in deliverability and low bioavailability. In this review, we explore the potential of resveratrol in DED treatment based on various\n                    <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                    studies.\n                  <\/jats:p>","DOI":"10.4103\/ijo.ijo_3204_22","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T11:10:52Z","timestamp":1680952252000},"page":"1270-1275","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Resveratrol for dry eye disease \u2013 Hope or Hype?"],"prefix":"10.4103","volume":"71","author":[{"given":"Rohit","family":"Shetty","sequence":"first","affiliation":[{"name":"Department of Cornea and Refractive Surgery, Narayana Nethralaya Eye Hospital, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth D","family":"Joshi","sequence":"additional","affiliation":[{"name":"Stem Cell Research Lab, GROW Lab, Narayana Nethralaya Foundation, Narayana Nethralaya, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krithikaa","family":"Mahendran","sequence":"additional","affiliation":[{"name":"Stem Cell Research Lab, GROW Lab, Narayana Nethralaya Foundation, Narayana Nethralaya, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitra","family":"Jayadev","sequence":"additional","affiliation":[{"name":"Department of Vitreoretina, Narayana Nethralaya Eye Hospital, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debashish","family":"Das","sequence":"additional","affiliation":[{"name":"Stem Cell Research Lab, GROW Lab, Narayana Nethralaya Foundation, Narayana Nethralaya, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","article-title":"TFOS DEWS II pain and sensation report","volume":"15","author":"Belmonte","year":"2017","journal-title":"Ocul Surf"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/jamaophthalmol.2022.4394","article-title":"Prevalence and incidence of dry eye and meibomian gland dysfunction in the United States:A systematic review and meta-analysis","volume":"140","author":"McCann","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4103\/ijo.IJO_698_17","article-title":"Prevalence and risk factors of dry eye disease in North India:Ocular surface disease index-based cross-sectional hospital study","volume":"66","author":"Titiyal","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"R4-20240828","article-title":"The global prevalence of dry eye disease and its association with economy:A systematic review","author":"Wan","year":"2019","journal-title":"Research Square"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/eye.2017.289","article-title":"Assessment and management of dry eye disease","volume":"32","author":"Buckley","year":"2018","journal-title":"Eye (Lond)"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"160","DOI":"10.18773\/austprescr.2018.048","article-title":"Dry eye disease:When to treat and when to refer","volume":"41","author":"Findlay","year":"2018","journal-title":"Aust Prescr"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"830853","DOI":"10.3389\/fmed.2022.830853","article-title":"Ocular surface ion-channels are closely related to dry eye:Key research focus on innovative drugs for dry eye","volume":"9","author":"Yang","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1167\/iovs.02-0581","article-title":"Apoptosis of ocular surface cells in experimentally induced dry eye","volume":"44","author":"Yeh","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"e0147847","DOI":"10.1371\/journal.pone.0147847","article-title":"Low serum 25-hydroxyvitamin D levels are associated with dry eye syndrome","volume":"11","author":"Yoon","year":"2016","journal-title":"PLoS One"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/tvst.5.6.16","article-title":"Lower vitamin D level and distinct tear cytokine profile were observed in patients with mild dry eye signs but exaggerated symptoms","volume":"5","author":"Shetty","year":"2016","journal-title":"Transl Vis Sci Technol"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.sjopt.2014.06.002","article-title":"Dry eye disease:A review of diagnostic approaches and treatments","volume":"28","author":"Lin","year":"2014","journal-title":"Saudi J Ophthalmol"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cyto.2018.02.009","article-title":"Effect of tear supplements on signs, symptoms and inflammatory markers in dry eye","volume":"105","author":"Martin","year":"2018","journal-title":"Cytokine"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.clindermatol.2015.11.009","article-title":"An eye on nutrition:The role of vitamins, essential fatty acids, and antioxidants in age-related macular degeneration, dry eye syndrome, and cataract","volume":"34","author":"McCusker","year":"2016","journal-title":"Clin Dermatol"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/antiox10020190","article-title":"Evidence of polyphenols efficacy against dry eye disease","volume":"10","author":"Favero","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/biomedicines6030091","article-title":"Resveratrol:A double-edged sword in health benefits","volume":"6","author":"Salehi","year":"2018","journal-title":"Biomedicines"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4062\/biomolther.2018.176","article-title":"Resveratrol:Twenty years of growth, development and controversy","volume":"27","author":"Pezzuto","year":"2019","journal-title":"Biomol Ther (Seoul)"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/nu8040200","article-title":"Resveratrol and ophthalmic diseases","volume":"8","author":"Abu-Amero","year":"2016","journal-title":"Nutrients"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-0030-1248725","article-title":"Moderate red wine consumption and cardiovascular disease risk:Beyond the \u201cFrench paradox\u201d","volume":"36","author":"Lippi","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/0140-6736(92)91277-F","article-title":"Wine, alcohol, platelets, and the French paradox for coronary heart disease","volume":"339","author":"Renaud","year":"1992","journal-title":"Lancet"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"17187","DOI":"10.1074\/jbc.M501250200","article-title":"Mechanism of human SIRT1 activation by resveratrol","volume":"280","author":"Borra","year":"2005","journal-title":"J Biol Chem"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2012.04.003","article-title":"SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function","volume":"15","author":"Price","year":"2012","journal-title":"Cell Metab"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2017.10.002","article-title":"Resveratrol activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced inflammation and oxidative stress","volume":"115","author":"Chiang","year":"2018","journal-title":"Neurochem Int"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0006-2952(01)00775-4","article-title":"Immunomodulatory activity of resveratrol:Suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production","volume":"62","author":"Gao","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1021\/jo3002134","article-title":"Antioxidant activity of trans-resveratrol toward hydroxyl and hydroperoxyl radicals:A quantum chemical and computational kinetics study","volume":"77","author":"Iuga","year":"2012","journal-title":"J Org Chem"},{"key":"R25-20240828","first-page":"9845","article-title":"Resveratrol suppresses human cervical carcinoma cell proliferation and elevates apoptosis via the mitochondrial and p53 signaling pathways","volume":"15","author":"Li","year":"2018","journal-title":"Oncol Lett"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"6819281","DOI":"10.1155\/2017\/6819281","article-title":"Cardioprotective effect of resveratrol in a postinfarction heart failure model","volume":"2017","author":"Riba","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"R27-20240828","first-page":"1269","article-title":"Anti-inflammatory activity of resveratrol prevents inflammation by inhibiting NF-kappaB in animal models of acute pharyngitis","volume":"17","author":"Zhou","year":"2018","journal-title":"Mol Med Rep"},{"key":"R28-20240828","doi-asserted-by":"crossref","first-page":"12242","DOI":"10.1038\/s41598-017-12496-z","article-title":"Resveratrol reverses the adverse effects of bevacizumab on cultured ARPE-19 cells","volume":"7","author":"Subramani","year":"2017","journal-title":"Sci Rep"},{"key":"R29-20240828","first-page":"1707","article-title":"Resveratrol protects retinal ganglion cells against ischemia induced damage by increasing Opa1 expression","volume":"46","author":"Pang","year":"2020","journal-title":"Int J Mol Med"},{"key":"R30-20240828","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/med.21565","article-title":"Health benefits of resveratrol:Evidence from clinical studies","volume":"39","author":"Singh","year":"2019","journal-title":"Med Res Rev"},{"key":"R31-20240828","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cyto.2015.03.016","article-title":"Resveratrol attenuates CXCL11 expression induced by proinflammatory cytokines in retinal pigment epithelial cells","volume":"74","author":"Kutty","year":"2015","journal-title":"Cytokine"},{"key":"R32-20240828","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/aos.14892","article-title":"Oxidative and antioxidative stress markers in dry eye disease:A systematic review and meta-analysis","volume":"100","author":"Navel","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"R33-20240828","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/BF00164671","article-title":"Oxidative reactions in the tear fluid of patients suffering from dry eyes","volume":"233","author":"Augustin","year":"1995","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R34-20240828","first-page":"1477","article-title":"Decreased expression of antioxidant enzymes in the conjunctival epithelium of dry eye (Sjogren's syndrome) and its possible contribution to the development of ocular surface oxidative injuries","volume":"23","author":"Cejkova","year":"2008","journal-title":"Histol Histopathol"},{"key":"R35-20240828","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1167\/iovs.12-10325","article-title":"Evaluation of lipid oxidative stress status in Sjogren syndrome patients","volume":"54","author":"Wakamatsu","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R36-20240828","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1167\/iovs.08-2666","article-title":"Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation","volume":"50","author":"Kubota","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R37-20240828","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/09273948.2018.1497664","article-title":"Topical quercetin and resveratrol protect the ocular surface in experimental dry eye disease","volume":"27","author":"Abengozar-Vela","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"R38-20240828","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/ICO.0b013e31803dcda2","article-title":"Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome","volume":"26","author":"Yoon","year":"2007","journal-title":"Cornea"},{"key":"R39-20240828","first-page":"862","article-title":"Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease","volume":"16","author":"Enriquez-de-Salamanca","year":"2010","journal-title":"Mol Vis"},{"key":"R40-20240828","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/09273948.2011.618902","article-title":"Roles of IL-8 in ocular inflammations:A review","volume":"19","author":"Ghasemi","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"R41-20240828","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1167\/iovs.14-15708","article-title":"The effect of resveratrol on protecting corneal epithelial cells from cytotoxicity caused by moxifloxacin and benzalkonium chloride","volume":"56","author":"Tsai","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R42-20240828","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1097\/ICO.0000000000002495","article-title":"Resveratrol rescues human corneal epithelial cells cultured in hyperosmolar conditions:Potential for dry eye disease treatment","volume":"39","author":"Shetty","year":"2020","journal-title":"Cornea"},{"key":"R43-20240828","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3889\/oamjms.2020.5305","article-title":"Topical instillation of resveratrol preconditioned Wharton's jelly mesenchymal stem cell secretome preserves ocular surface in experimental model of severe dry eye disease","volume":"8","author":"Astaridewi","year":"2020","journal-title":"Open Access Maced J Med Sci"},{"key":"R44-20240828","first-page":"1013444","article-title":"Ameliorative potential of resveratrol in dry eye disease by restoring mitochondrial function","volume":"2022","author":"Chen","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"R45-20240828","doi-asserted-by":"crossref","first-page":"850757","DOI":"10.3389\/fchem.2022.850757","article-title":"Recent developments of nanostructures for the ocular delivery of natural compounds","volume":"10","author":"Razavi","year":"2022","journal-title":"Front Chem"},{"key":"R46-20240828","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jfoodeng.2011.07.034","article-title":"Preparation and physicochemical characterization of trans-resveratrol nanoparticles by temperature-controlled antisolvent precipitation","volume":"108","author":"Kim","year":"2012","journal-title":"J Food Eng"},{"key":"R47-20240828","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.foodres.2014.05.059","article-title":"Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol","volume":"62","author":"Pandita","year":"2014","journal-title":"Food Res Int"},{"key":"R48-20240828","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.bbrc.2004.02.164","article-title":"Human hepatic cell uptake of resveratrol:Involvement of both passive diffusion and carrier-mediated process","volume":"316","author":"Lancon","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"R49-20240828","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1089\/152308601317203567","article-title":"Biological effects of resveratrol","volume":"3","author":"Bhat","year":"2001","journal-title":"Antioxid Redox Signal"},{"key":"R50-20240828","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1749-6632.2010.05842.x","article-title":"Bioavailability of resveratrol","volume":"1215","author":"Walle","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"R51-20240828","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2147\/IJN.S29710","article-title":"Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers:Evaluation of antioxidant potential for dermal applications","volume":"7","author":"Gokce","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"R52-20240828","doi-asserted-by":"crossref","first-page":"E116","DOI":"10.3390\/molecules21010116","article-title":"Skin delivery and in vitro biological evaluation of trans-resveratrol-loaded solid lipid nanoparticles for skin disorder therapies","volume":"21","author":"Rigon","year":"2016","journal-title":"Molecules"},{"key":"R53-20240828","first-page":"535","article-title":"Skin delivery of resveratrol encapsulated lipidic formulation for melanoma chemoprevention","volume":"36","author":"Ravikumar","year":"2019","journal-title":"J Microencapsul"},{"key":"R54-20240828","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jddst.2018.10.017","article-title":"Improvement of the solubility, photostability, antioxidant activity and UVB photoprotection of trans-resveratrol by essential oil based microemulsions for topical application","volume":"48","author":"Lv","year":"2018","journal-title":"J Drug Deliv Sci Technol"},{"key":"R55-20240828","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2015.06.040","article-title":"Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo","volume":"213","author":"Cote","year":"2015","journal-title":"J Control Release"},{"key":"R56-20240828","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1208\/s12249-011-9584-3","article-title":"Cyclodextrin-based nanosponges for delivery of resveratrol: In vitro characterisation, stability, cytotoxicity and permeation study","volume":"12","author":"Ansari","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"R57-20240828","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jphotobiol.2019.04.012","article-title":"Fabrication of resveratrol coated gold nanoparticles and investigation of their effect on diabetic retinopathy in streptozotocin induced diabetic rats","volume":"195","author":"Dong","year":"2019","journal-title":"J Photochem Photobiol B"},{"key":"R58-20240828","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.ijbiomac.2017.04.117","article-title":"Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles:For efficient intra ocular pressure reduction","volume":"104","author":"Natesan","year":"2017","journal-title":"Int J Biol Macromol"},{"key":"R59-20240828","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1049\/iet-nbt.2016.0069","article-title":"RES-loaded pegylated CS NPs:For efficient ocular delivery","volume":"11","author":"Pandian","year":"2017","journal-title":"IET Nanobiotechnol"},{"key":"R60-20240828","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1080\/03639045.2020.1828909","article-title":"New resveratrol micelle formulation for ocular delivery:Characterization and in vitro\/in vivo evaluation","volume":"46","author":"Li","year":"2020","journal-title":"Drug Dev Ind Pharm"},{"key":"R61-20240828","doi-asserted-by":"crossref","first-page":"122028","DOI":"10.1016\/j.ijpharm.2022.122028","article-title":"Improved ocular delivery of quercetin and resveratrol:A comparative study between binary and ternary cyclodextrin complexes","volume":"624","author":"Krstic","year":"2022","journal-title":"Int J Pharm"},{"key":"R62-20240828","doi-asserted-by":"crossref","first-page":"122281","DOI":"10.1016\/j.ijpharm.2022.122281","article-title":"Pluronic(R)\/casein micelles for ophthalmic delivery of resveratrol:In vitro, ex vivo, and in vivo tests","volume":"628","author":"Vivero-Lopez","year":"2022","journal-title":"Int J Pharm"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_3204_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:29:43Z","timestamp":1786724983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_3204_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_3204_22","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"2022-12-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}